| DC Field | Value | Language |
|---|
| dc.contributor.author | Khokhlov, A. L. | - |
| dc.contributor.author | Yaichkov, I. I. | - |
| dc.contributor.author | Shetnev, A. A. | - |
| dc.contributor.author | Panova, V. A. | - |
| dc.contributor.author | Efimova, Yu. A. | - |
| dc.date.accessioned | 2025-01-24T07:00:41Z | - |
| dc.date.available | 2025-01-24T07:00:41Z | - |
| dc.date.issued | 2024 | - |
| dc.identifier.citation | Identification and synthesis of metabolites of 4-(5-methyl-1,3,4-oxadiazole-2-yl)-benzenesulfonamide / A.L. Khokhlov, I.I. Yaichkov, A.A. Shetnev [et al.] // Research Results in Pharmacology. - 2024. - Vol.10, №4.-P. 15-27. - Doi: 10.18413/rrpharmacology.10.498. | ru |
| dc.identifier.uri | http://dspace.bsu.edu.ru/handle/123456789/64410 | - |
| dc.description.abstract | 4-(5-methyl-1,3,4-oxadiazole-2-yl)-benzenesulfonamide is a new selective type II carbonic anhydrase inhibitor with local action through instillation into the eyes. For a complete pharmacokinetic study of this drug, it is necessary to detect and synthesize its metabolites for their systemic exposure evaluation | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | pharmacology | ru |
| dc.subject | glaucoma | ru |
| dc.subject | biotransformation | ru |
| dc.subject | selective carbonic anhydrase II inhibitor | ru |
| dc.subject | benzenesulfonamide | ru |
| dc.title | Identification and synthesis of metabolites of 4-(5-methyl-1,3,4-oxadiazole-2-yl)-benzenesulfonamide | ru |
| dc.type | Article | ru |
| Appears in Collections: | Vol. 10, № 4
|
